spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman


Professor Howell has over 20 years’ life science commercialisation experience, supporting companies’ development and profitability. He founded Innova Partnerships in 2006, where he has been instrumental in creating over a dozen life science start-ups and raised in excess of £100m in financing. Steve oversaw the exit of Innova Biosciences in 2016-2017 to SYGNIS AG, Innova Partnerships’ second exit. He has held positions at Unilever plc, and was previously Director of Business Development at Alere Inc. and Research Director at Unipath Ltd. In 2015 he was made Visiting Professor of Commercial Innovation at King's College, London.

Professor Steve Howell, Non-Executive Chairman, Arcis Biotechnology, commented:“The Arcis sample preparation technology has enormous potential across many application areas, including diagnostics and genetic understanding. I am excited to be joining the team as we build the business to bring products to market that will have real and positive impact on patient quality of life.”

Paul Foulger, Non-Executive Director, Arcis Biotechnology, said:"We have an exciting opportunity to build a world-leading and highly valuable biotech based on Arcis’ current technology platform and future ambitions. Steve’s considerable experience, expertise and network will make a significant contribution to achieving that goal and delivering maximum value to shareholders.”

Peter Whitehurst, CEO, Arcis Biotechnology, said: “I would like to thank Paul for his time as interim Chairman, and for working with the Executive Directors to bring Steve in for the next exciting phase of development at Arcis.”

The appointment of Professor Howell as Non-Executive Chairman follows the Company’s recent announcements of strategic distribution and licensing agreements, with Opentrons and Mirnax Biosens respectively. These agreements extend the reach of Arcis’ sample preparation and preservation technology in two areas of the life sciences industry – high throughput sample prep with robotics, and the development of early disease diagnostics.
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Leading pharma packaging companies commit to supply for Covid-19 fight

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in.
More info >>


White Papers

Using Device Strategy to Drive R&D Productivity

Phillips-Medisize


More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement